# GL-ICNN: An End-To-End Interpretable Convolutional Neural Network for the Diagnosis and Prediction of Alzheimer's Disease

arXiv: https://arxiv.org/abs/2501.11715 · HTML: https://mlsanity.com/paper/2501.11715/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 8 of its 18 references that are in the map.
- First posted on arXiv 20 Jan 2025.

## Builds on (most cited first, 8 of 8)

- [Very Deep Convolutional Networks for Large-Scale Image Recognition](https://mlsanity.com/paper/1409.1556/) (2014)
- [Densely Connected Convolutional Networks](https://mlsanity.com/paper/1608.06993/) (2016)
- [Explainable Artificial Intelligence (XAI): Concepts, Taxonomies, Opportunities and Challenges toward Responsible AI](https://mlsanity.com/paper/1910.10045/) (2019)
- [The (Un)reliability of saliency methods](https://mlsanity.com/paper/1711.00867/) (2017)
- [Convolutional Neural Networks for Classification of Alzheimer's Disease: Overview and Reproducible Evaluation](https://mlsanity.com/paper/1904.07773/) (2019)
- [Accuracy, Interpretability, and Differential Privacy via Explainable Boosting](https://mlsanity.com/paper/2106.09680/) (2021)
- [Cross-Cohort Generalizability of Deep and Conventional Machine Learning for MRI-based Diagnosis and Prediction of Alzheimer's Disease](https://mlsanity.com/paper/2012.08769/) (2020)
- [An Interpretable Machine Learning Model with Deep Learning-based Imaging Biomarkers for Diagnosis of Alzheimer's Disease](https://mlsanity.com/paper/2308.07778/) (2023)

## Abstract (arXiv)

Deep learning methods based on Convolutional Neural Networks (CNNs) have shown great potential to improve early and accurate diagnosis of Alzheimer's disease (AD) dementia based on imaging data. However, these methods have yet to be widely adopted in clinical practice, possibly due to the limited interpretability of deep learning models. The Explainable Boosting Machine (EBM) is a glass-box model but cannot learn features directly from input imaging data. In this study, we propose a novel interpretable model that combines CNNs and EBMs for the diagnosis and prediction of AD. We develop an innovative training strategy that alternatingly trains the CNN component as a feature extractor and the EBM component as the output block to form an end-to-end model. The model takes imaging data as input and provides both predictions and interpretable feature importance measures. We validated the proposed model on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset and the Health-RI Parelsnoer Neurodegenerative Diseases Biobank (PND) as an external testing set. The proposed model achieved an area-under-the-curve (AUC) of 0.956 for AD and control classification, and 0.694 for the prediction of conversion of mild cognitive impairment (MCI) to AD on the ADNI cohort. The proposed model is a glass-box model that achieves a comparable performance with other state-of-the-art black-box models. Our code is publicly available at: https://anonymous.4open.science/r/GL-ICNN.